Attending Physician in Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center
Radiation Oncology
Dr. Nils D. Arvold, MD
|
|
Give Review
Doctor Nils D. Arvold, MD practices Radiation Oncology. He went to medical school at Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School is ranked 1 in research and 12 in primary care medicine Nils D. Arvold is also a published physician. He has 29 publication published. The most recent publication is: A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy. He accepts Medicare.
Publications
- A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma.
- A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy.
- Steroid and anticonvulsant prophylaxis for stereotactic radiosurgery: Large variation in physician recommendations.
- In Reply to Levra et al.
- Local therapies for brain metastases, competing risks, and overall survival.
- Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma.
- Tumor Hypoxia Response After Targeted Therapy in EGFR-Mutant Non-Small Cell Lung Cancer: Proof of Concept for FMISO-PET.
- Invasive lobular carcinoma of the breast: local recurrence after breast-conserving therapy by subtype approximation and surgical margin.
- Local control after fractionated stereotactic radiation therapy for brain metastases.
- Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma.
- Hospitalization burden and survival among older glioblastoma patients.
- Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
- Outcomes in stage I testicular seminoma: A population-based study of 9193 patients.
- Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases.
- Pathologic characteristics of second breast cancers after breast conservation for ductal carcinoma in situ.
- Treatment options and outcomes for glioblastoma in the elderly patient.
- Berberine sensitizes human glioma cells, but not normal glial cells, to ionizing radiation in vitro.
- Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy.
- Marantic Endocarditis With Cardioembolic Strokes Mimicking Leptomeningeal Metastases in Breast Cancer.
- Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low or intermediate risk disease.
- Pancreatic cancer tumor size on CT scan versus pathologic specimen: implications for radiation treatment planning.
- Visual outcome and tumor control after conformal radiotherapy for patients with optic nerve sheath meningioma.
- Signal transduction molecules in gliomas of all grades.
- Maternal HIV-1 DNA load and mother-to-child transmission.
- Radiation-induced caspase-8 mediates p53-independent apoptosis in glioma cells.
- Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.
- Hypoxia-induced radioresistance is independent of hypoxia-inducible factor-1A in vitro.
- PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas.
Schools
Harvard Medical School
Massachusetts General Hospital
Brigham and Women39s Hospital
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Education
-
Brigham and Women's Hospital -
Massachusetts General Hospital -
Harvard Medical School
Hospital
-
Brigham and Women's Hospital -
Dana-Farber Cancer Institute
Drug Facts
| NPI NUMBER | 1962607499 | |
| NPPES Provider LastName | ARVOLD | |
| NPPES Provider FirstName | NILS | |
| NPPES Provider ZIPCode | 021156110 | |
| NPPES Provider State | MA | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 48.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1962607499 |
| Last Name Of The Provider | ARVOLD |
| First Name Of The Provider | NILS |
| View All |
Similar Doctors
|
|
Dr. Ira J. Spiro, MD |
|
|
Dr. Yolanda D. Tseng, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Konstantin A. Kovtun, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ravi A. Chandra, MD |
|
|
Dr. Andrea Ng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tracy A. Balboni, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Helen A. Shih, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Michele Albert, MD
This Doctor is OpenDoctor Recommended.
|